Countplus has announced that it has appointed a senior business executive to its board, increasing its membership to six.
Kate Hill currently serves as director of the Westmead Medical Research Foundation and as a member of the Finance and Risk Committee, according to an ASX announcement.
In addition, she also serves as company secretary for Novogen Limited, the statement said.
Ms Hill was also formerly a board member for the Deloitte board of partners (Australia) and chairman of a family company board.
The Countplus board will have six directors following Ms Hill’s appointment – five non-executive and one executive.
Countplus non-executive chair Ray Kellerman said the board welcomes the inclusion of Ms Hill who, among her many business accolades, was the first female partner admitted to the Deloitte Australia board of partners and the first female member of the Deloitte senior leadership team.
APRA-regulated super funds could create better member outcomes by taking the sam...
Australian high-net-worth investors lost more money than their global counterpar...
The negative impact of COVID-related market volatility on clients’ super inves...
Get the latest news! Subscribe to the ifa bulletin
Get notifications in real time and stay up to date with content that matters to you.
